Ascot Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 12-12-2024
- Paid Up Capital ₹ 0.45 M
as on 12-12-2024
- Company Age 34 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 M
as on 12-12-2024
- Revenue -1.99%
(FY 2022)
- Profit -86.01%
(FY 2022)
- Ebitda -77.90%
(FY 2022)
- Net Worth -8.82%
(FY 2022)
- Total Assets -13.63%
(FY 2022)
About Ascot Pharmachem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.45 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Bhavesh Pradhan, Purvish Diwanji, Vijaykumar Patel, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232GJ1990PTC014064
- Company No.
014064
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ascot Pharmachem?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavesh Pradhan  | Director | 17-Aug-2024 | Current |
| Purvish Diwanji | Director | 17-Aug-2024 | Current |
Vijaykumar Patel  | Director | 19-Jul-1990 | Current |
| Yogesh Pathak | Director | 21-Sep-2009 | Current |
| Jayneshpuri Goswami | Director | 17-Aug-2024 | Current |
Financial Performance and Corporate Structure Insights of Ascot Pharmachem.
Ascot Pharmachem Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.99% decrease. The company also saw a substantial fall in profitability, with a 86.01% decrease in profit. The company's net worth dipped by a decrease of 8.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ascot Pharmachem?
In 2020, Ascot Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Satyajit Speciality Chemicals Private LimitedActive 45 years 3 monthsPurvish Diwanji is a mutual person
_PRIVATE_LIMITED.webp)
Aci Industrial Organic Private LimitedActive 26 years 9 monthsBhavesh Pradhan and Purvish Diwanji are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 22 Mar 1991 | ₹1.00 M | Satisfied |
How Many Employees Work at Ascot Pharmachem?
Unlock and access historical data on people associated with Ascot Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ascot Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ascot Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
